• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

第三代头孢菌素

Third-generation cephalosporins.

作者信息

Klein N C, Cunha B A

机构信息

Infectious Disease Division, Winthrop-University Hospital, Mineola, New York, USA.

出版信息

Med Clin North Am. 1995 Jul;79(4):705-19. doi: 10.1016/s0025-7125(16)30034-7.

DOI:10.1016/s0025-7125(16)30034-7
PMID:7791418
Abstract

Third-generation cephalosporins are broad-spectrum antimicrobial agents useful in a variety of clinical situations. No one cephalosporin is appropriate for all infectious disease problems. Cefotaxime and ceftizoxime have the best gram-positive coverage of the third-generation agents. Ceftazidime and cefoperazone are the only third-generation drugs that provide antipseudomonal coverage. Ceftriaxone's long half-life allows for once-daily dosing, making ceftriaxone an excellent drug for outpatient antibiotic therapy of community-acquired infections. Ceftriaxone is also useful for the treatment of Lyme disease and sexually transmitted diseases. The third-generation cephalosporins except for cefoperazone penetrate cerebrospinal fluid and are indicated for the treatment of bacterial meningitis. Their proven record of clinical efficacy, favorable pharmacokinetics, and low frequency of adverse effects make third-generation cephalosporins the preferred antibiotic in many clinical situations.

摘要

第三代头孢菌素是广谱抗菌剂,可用于多种临床情况。没有一种头孢菌素适用于所有传染病问题。头孢噻肟和头孢唑肟在第三代药物中对革兰氏阳性菌的覆盖范围最佳。头孢他啶和头孢哌酮是仅有的提供抗假单胞菌覆盖的第三代药物。头孢曲松的半衰期长,允许每日给药一次,这使头孢曲松成为社区获得性感染门诊抗生素治疗的理想药物。头孢曲松也可用于治疗莱姆病和性传播疾病。除头孢哌酮外,第三代头孢菌素可穿透脑脊液,适用于治疗细菌性脑膜炎。它们已被证实的临床疗效记录、良好的药代动力学特性以及低不良反应发生率,使第三代头孢菌素在许多临床情况下成为首选抗生素。

相似文献

1
Third-generation cephalosporins.第三代头孢菌素
Med Clin North Am. 1995 Jul;79(4):705-19. doi: 10.1016/s0025-7125(16)30034-7.
2
Third-generation cephalosporins: a critical evaluation.第三代头孢菌素:批判性评价
Clin Pharm. 1984 Jul-Aug;3(4):351-73.
3
The selection and use of cephalosporins: a review.头孢菌素的选择与应用:综述
Adv Ther. 1995 Mar-Apr;12(2):83-101.
4
[Review of oral cephalosporins. Basis for a rational choice].[口服头孢菌素综述。合理选择的依据]
Medicina (B Aires). 1994;54(5 Pt 1):439-58.
5
In vitro activity, pharmacokinetics, clinical efficacy, safety and pharmacoeconomics of ceftriaxone compared with third and fourth generation cephalosporins: review.头孢曲松与第三代和第四代头孢菌素相比的体外活性、药代动力学、临床疗效、安全性及药物经济学:综述
J Chemother. 2005 Feb;17(1):3-24.
6
Role of cephalosporins in the treatment of bacterial meningitis in adults. Overview with special emphasis on ceftazidime.头孢菌素类药物在成人细菌性脑膜炎治疗中的作用。重点介绍头孢他啶的综述。
Am J Med. 1985 Aug 9;79(2A):56-61. doi: 10.1016/0002-9343(85)90262-1.
7
Third generation cephalosporins.第三代头孢菌素
Infect Dis Clin North Am. 1989 Sep;3(3):595-612.
8
Cefotaxime. A pharmacoeconomic review of its use in the treatment of infections.头孢噻肟。对其用于治疗感染的药物经济学综述。
Pharmacoeconomics. 1998 Jan;13(1 Pt 1):91-106. doi: 10.2165/00019053-199813010-00009.
9
Ceftizoxime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.头孢唑肟:抗菌活性、药代动力学特性及治疗用途综述
Drugs. 1985 Apr;29(4):281-329. doi: 10.2165/00003495-198529040-00001.
10
Penetration of newer cephalosporins into cerebrospinal fluid.新型头孢菌素在脑脊液中的穿透情况。
Rev Infect Dis. 1989 Jul-Aug;11(4):526-48. doi: 10.1093/clinids/11.4.526.

引用本文的文献

1
liver abscesses: pathogenesis, treatment, and ongoing challenges.肝脓肿:发病机制、治疗及当前挑战
Infect Immun. 2025 Aug 12;93(8):e0050824. doi: 10.1128/iai.00508-24. Epub 2025 Jul 3.
2
the impact of stakeholder decision-making on antimicrobial resistance evolution.利益相关者决策对抗菌药物耐药性演变的影响。
Microbiology (Reading). 2025 Feb;171(2). doi: 10.1099/mic.0.001534.
3
Intricate interplay of CRISPR-Cas systems, anti-CRISPR proteins, and antimicrobial resistance genes in a globally successful multi-drug resistant Klebsiella pneumoniae clone.
在一个全球广泛传播的多重耐药肺炎克雷伯菌克隆中,CRISPR-Cas系统、抗CRISPR蛋白和抗菌耐药基因之间复杂的相互作用
Genome Med. 2025 Jan 30;17(1):9. doi: 10.1186/s13073-025-01428-6.
4
A Saudi Woman with Ceftriaxone Induced Fixed Drug Eruption.一名患有头孢曲松诱导的固定性药疹的沙特女性。
Case Rep Dermatol Med. 2024 Mar 15;2024:9975455. doi: 10.1155/2024/9975455. eCollection 2024.
5
QSAR analysis of five generations of cephalosporins to establish the structural basis of activity against methicillin-resistant and methicillin-sensitive Staphylococcus aureus.对五代头孢菌素进行定量构效关系分析,以确立其对耐甲氧西林金黄色葡萄球菌和甲氧西林敏感金黄色葡萄球菌活性的结构基础。
Mol Divers. 2024 Oct;28(5):3027-3043. doi: 10.1007/s11030-023-10730-7. Epub 2023 Sep 21.
6
Extended-spectrum β-lactamase-producing E. coli from retail meat and workers: genetic diversity, virulotyping, pathotyping and the antimicrobial effect of silver nanoparticles.零售肉品及其从业人员中产超广谱β-内酰胺酶大肠杆菌:遗传多样性、毒力分型、血清分型和银纳米粒子的抗菌效果。
BMC Microbiol. 2023 Aug 7;23(1):212. doi: 10.1186/s12866-023-02948-0.
7
Ceftriaxone 1 g versus 2 g per day, for the treatment of community-acquired pneumonia: a retrospective cohort study.头孢曲松 1 克/天与 2 克/天治疗社区获得性肺炎:一项回顾性队列研究。
Intern Emerg Med. 2023 Oct;18(7):1919-1927. doi: 10.1007/s11739-023-03372-y. Epub 2023 Jul 20.
8
The CREPE Score: A Predictive Tool for Third-Generation Cephalosporin-Resistant Enterobacterales Pneumonia in Community Settings.CREPE评分:社区环境中耐第三代头孢菌素肠杆菌科细菌肺炎的预测工具。
Infect Drug Resist. 2023 Jun 27;16:4159-4169. doi: 10.2147/IDR.S417863. eCollection 2023.
9
Attitudes and Practices of the Use of Third-Generation Cephalosporins among Medical Doctors Practicing in Cameroon.喀麦隆执业医生使用第三代头孢菌素的态度和做法。
Int J Clin Pract. 2023 Feb 15;2023:8074413. doi: 10.1155/2023/8074413. eCollection 2023.
10
Mitochondrial Side Effects of Surgical Prophylactic Antibiotics Ceftriaxone and Rifaximin Lead to Bowel Mucosal Damage.手术预防性抗生素头孢曲松和利福昔明的线粒体副作用导致肠黏膜损伤。
Int J Mol Sci. 2022 May 3;23(9):5064. doi: 10.3390/ijms23095064.